Lucybeth Nieves
Expertise in
11
conditions

Dr. Lucybeth Nieves

Oncology
2131 South 17th Street, 
Wilmington, NC 
Offers Telehealth
24 Years of Experience
Expertise in
11
conditions
2131 South 17th Street, 
Wilmington, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lucybeth Nieves is an Oncologist in Wilmington, North Carolina. Dr. Nieves has been practicing medicine for over 24 years is highly rated in 11 conditions, according to our data. Her top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Sertoli-Leydig Cell Tumor, Bladder Reconstruction, and Gastrostomy.

Her clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Puerto Rico School Of Medicine, 2002.0
Residency
University of CT Health Center, John N Dempsey Hos
Specialties
Oncology
Licenses
Obstetrics & Gynecology in NC
Board Certifications
Obstetrics & Gynecology
Hospital Affiliations
Novant Health Brunswick Medical Center
Novant Health New Hanover Regional Medical Center
Languages Spoken
English
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Novant Health Cancer Institute - New Hanover (Gynecologic Oncology)
2131 South 17th Street, Wilmington, NC 28401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Other, Drug, Procedure, Biological
Study Drugs: Carboplatin, Paclitaxel, Pembrolizumab
Study Phase: Phase 3
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Atezolizumab, Bevacizumab, Pegylated liposomal doxorubicin hydrochloride
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2025
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: September 17, 2025
Intervention Type: Other, Drug
View 3 Less Clinical Trials
Similar Doctors
Andrew Schreiber
Expertise in
80
conditions
Dr. Andrew Schreiber
Oncology | Hematology
Expertise in
80
conditions
Dr. Andrew Schreiber
Oncology | Hematology

Novant Health Cancer Institute - New Hanover (Oncology/Hematology)

2131 South 17th Street, 
Wilmington, NC 
 (0.1 miles away)
910-662-1730
Experience:
24+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andrew Schreiber is a Hematologist and an Oncologist in Wilmington, North Carolina. Dr. Schreiber has been practicing medicine for over 24 years is highly rated in 80 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Expertise in
14
conditions
Dr. Lindsey H. Prochaska
Oncology | Hematology | Hematology Oncology
Expertise in
14
conditions
Dr. Lindsey H. Prochaska
Oncology | Hematology | Hematology Oncology

Novant Health Medical Group Coastal Region LLC

2131 S 17th St, 
Wilmington, NC 
 (0.1 miles away)
910-667-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lindsey Prochaska is an Oncologist and a Hematologist in Wilmington, North Carolina. Dr. Prochaska is highly rated in 14 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Intraductal Papilloma. Dr. Prochaska is currently accepting new patients.

John Belle
Expertise in
33
conditions
Dr. John Belle
Oncology | Hematology
Expertise in
33
conditions
Dr. John Belle
Oncology | Hematology

Novant Health Cancer Institute - Brunswick Forest (Oncology/Hematology)

1333 South Dickinson Drive, Suite 200, 
Leland, NC 
 (7.2 miles away)
910-667-3000
Experience:
22+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Belle is a Hematologist and an Oncologist in Leland, North Carolina. Dr. Belle has been practicing medicine for over 22 years is highly rated in 33 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nieves's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile